Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine with Chemoradiation for Head and Neck Cancer
NCT00270790Phase 2Completed
- Start
- May 2002
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amifostine in mucositis, hematological toxicity. Started May 2002; status: completed.
02
Drugs
amifostine
03
Conditions
mucositishematological toxicity
Beyond the preview
Go deeper on NCT00270790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00270790.